---
figid: PMC5412884__EMMM-9-558-g001
figtitle: Culturing human intestinal stem cells for regenerative applications in the
  treatment of inflammatory bowel disease
organisms:
- NA
pmcid: PMC5412884
filename: EMMM-9-558-g001.jpg
figlink: /pmc/articles/PMC5412884/figure/emmm201607260-fig-0001/
number: F1
caption: Activation of the WNT pathway inhibits phosphorylation‐induced degradation
  of β‐catenin mediated by Axin/APC/GSK3β, which precipitates nuclear translocation
  of β‐catenin and activation of target genes. BMP inhibition and EGF activation increase
  nuclear β‐catenin levels, due to phosphorylation and inactivation of GSK3β or phosphorylation
  of β‐catenin itself. Similarly, CHIR99021 can increase WNT signaling by inactivation
  of GSK3β. PGE2 can promote β‐catenin stability through suppression of GSK3β, but
  perhaps also through interaction between PGE2‐R subunits and Axin, activation of
  cAMP/PKA and PI3K/PIP3/AKT activity. SB202190 inhibits p38, thereby decreasing ligand‐driven
  degradation of the EGF receptor. Delta like canonical Notch ligand 1/4 (DLL1/4)
  can activate membrane‐bound Notch, and the adaptor protein NUMB can associate with
  unphosphorylated β‐catenin, precipitating its lysosomal degradation, thereby dampening
  WNT activity.
papertitle: Culturing human intestinal stem cells for regenerative applications in
  the treatment of inflammatory bowel disease.
reftext: Fredrik EO Holmberg, et al. EMBO Mol Med. 2017 May;9(5):558-570.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9442608
figid_alias: PMC5412884__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5412884__F1
ndex: d67be81c-df00-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5412884__EMMM-9-558-g001.html
  '@type': Dataset
  description: Activation of the WNT pathway inhibits phosphorylation‐induced degradation
    of β‐catenin mediated by Axin/APC/GSK3β, which precipitates nuclear translocation
    of β‐catenin and activation of target genes. BMP inhibition and EGF activation
    increase nuclear β‐catenin levels, due to phosphorylation and inactivation of
    GSK3β or phosphorylation of β‐catenin itself. Similarly, CHIR99021 can increase
    WNT signaling by inactivation of GSK3β. PGE2 can promote β‐catenin stability through
    suppression of GSK3β, but perhaps also through interaction between PGE2‐R subunits
    and Axin, activation of cAMP/PKA and PI3K/PIP3/AKT activity. SB202190 inhibits
    p38, thereby decreasing ligand‐driven degradation of the EGF receptor. Delta like
    canonical Notch ligand 1/4 (DLL1/4) can activate membrane‐bound Notch, and the
    adaptor protein NUMB can associate with unphosphorylated β‐catenin, precipitating
    its lysosomal degradation, thereby dampening WNT activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT3A
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LGR5
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PTEN
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CTNNB1
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - DLL1
  - DLL4
  - NUMB
  - EGF
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - EPHB2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - KRAS
  - HRAS
  - NRAS
  - EGFR
  - SB202190
  - PGE
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
